Donald Kufe
Physician · New York Presbyterian Hospital
Credentials: · ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Mucins in cancer: function, prognosis and therapy
Review · Nature reviews. Cancer · 2009 · Sole author · 1,164 citations
Cancer Research · 1999 · 764 citations
Hybridoma · 1984 · First of 6 authors · 563 citations
122 papers
48 papers
- DS
44 papers · 3 as a fellow
- MS
43 papers
30 papers · 3 as a fellow
26 papers · 3 as a resident
25 papers
- DH
22 papers · 3 as a fellow
Grants
- 2002–2029
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
National Cancer Institute · R01
Contact PI · $8.8M · Dana-Farber Cancer Inst
- 2024–2029
Combining CDK7 and MUC1-C Inhibition to Target Different Subtypes of Small Cell Lung Cancer
National Cancer Institute · R01
PI · $2.1M · New York University School of Medicine
- 2014–2027
Extension of the Dana Farber Harvard Cancer Center Consortium for the ETCTN
National Cancer Institute · UM1
Contact PI · $25.9M · Dana-Farber Cancer Inst
- 2024–2026
MUC1-C Is a Target for Advancing Immunotherapy of Non-Small Cell Lung Cancer
National Cancer Institute · R21
Contact PI · $450.4K · Dana-Farber Cancer Inst
Clinical trials
- 1999–2001
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Study chair · Completed · Phase 1
Dana-Farber Cancer Institute
- 1996
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Study chair · Completed · Phase 1
National Cancer Institute (NCI)